These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32239237)

  • 21. Exercise or manual physiotherapy compared with a single session of physiotherapy for osteoporotic vertebral fracture: three-arm PROVE RCT.
    Barker KL; Newman M; Stallard N; Leal J; Minns Lowe C; Javaid MK; Noufaily A; Adhikari A; Hughes T; Smith DJ; Gandhi V; Cooper C; Lamb SE
    Health Technol Assess; 2019 Aug; 23(44):1-318. PubMed ID: 31456562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry.
    Ito K; Leslie WD
    Osteoporos Int; 2015 Aug; 26(8):2111-9. PubMed ID: 25807913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model.
    Si L; Winzenberg TM; Jiang Q; Palmer AJ
    Osteoporos Int; 2015 May; 26(5):1477-89. PubMed ID: 25567776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceptability of screening to prevent osteoporotic fractures: a qualitative study with older women.
    Emmett CL; Redmond NM; Peters TJ; Clarke S; Shepstone L; Lenaghan E; Shaw AR
    Fam Pract; 2012 Apr; 29(2):235-42. PubMed ID: 21908537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision.
    Yong JH; Masucci L; Hoch JS; Sujic R; Beaton D
    Osteoporos Int; 2016 Jan; 27(1):231-40. PubMed ID: 26275439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of secondary fracture prevention intervention for Medicare beneficiaries.
    Nayak S; Singer A; Greenspan SL
    J Am Geriatr Soc; 2021 Dec; 69(12):3435-3444. PubMed ID: 34343339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women.
    Stevenson M; Davis S; Lloyd-Jones M; Beverley C
    Health Technol Assess; 2007 Feb; 11(4):1-134. PubMed ID: 17280622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 3i hip fracture liaison service with nurse and physician co-management is cost-effective when implemented as a standard clinical program.
    Beaupre LA; Lier D; Smith C; Evens L; Hanson HM; Juby AG; Kivi P; Majumdar SR;
    Arch Osteoporos; 2020 Jul; 15(1):113. PubMed ID: 32699946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.
    Yoshimura M; Moriwaki K; Noto S; Takiguchi T
    Osteoporos Int; 2017 Feb; 28(2):643-652. PubMed ID: 27743068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women.
    Chandran M; Ganesan G; Tan KB; Reginster JY; Hiligsmann M
    Osteoporos Int; 2021 Jan; 32(1):133-144. PubMed ID: 32797250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women.
    Schousboe JT; Ensrud KE; Nyman JA; Melton LJ; Kane RL
    J Am Geriatr Soc; 2005 Oct; 53(10):1697-704. PubMed ID: 16181168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-utility analysis of fracture risk assessment using microRNAs compared with standard tools and no monitoring in the Austrian female population.
    Walter E; Dellago H; Grillari J; Dimai HP; Hackl M
    Bone; 2018 Mar; 108():44-54. PubMed ID: 29269173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.
    Moriwaki K; Noto S
    Osteoporos Int; 2017 Feb; 28(2):621-632. PubMed ID: 27699441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effective osteoporosis treatment thresholds in Greece.
    Makras P; Athanasakis K; Boubouchairopoulou N; Rizou S; Anastasilakis AD; Kyriopoulos J; Lyritis GP
    Osteoporos Int; 2015 Jul; 26(7):1949-57. PubMed ID: 25740208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osteoporosis case manager for patients with hip fractures: results of a cost-effectiveness analysis conducted alongside a randomized trial.
    Majumdar SR; Lier DA; Beaupre LA; Hanley DA; Maksymowych WP; Juby AG; Bell NR; Morrish DW
    Arch Intern Med; 2009 Jan; 169(1):25-31. PubMed ID: 19139320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries--an economic evaluation based on the fracture intervention trial.
    Ström O; Borgström F; Sen SS; Boonen S; Haentjens P; Johnell O; Kanis JA
    Osteoporos Int; 2007 Aug; 18(8):1047-61. PubMed ID: 17333449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study.
    Rubin KH; Rothmann MJ; Holmberg T; Høiberg M; Möller S; Barkmann R; Glüer CC; Hermann AP; Bech M; Gram J; Brixen K
    Osteoporos Int; 2018 Mar; 29(3):567-578. PubMed ID: 29218381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A group memory rehabilitation programme for people with traumatic brain injuries: the ReMemBrIn RCT.
    das Nair R; Bradshaw LE; Carpenter H; Clarke S; Day F; Drummond A; Fitzsimmons D; Harris S; Montgomery AA; Newby G; Sackley C; Lincoln NB
    Health Technol Assess; 2019 Apr; 23(16):1-194. PubMed ID: 31032782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
    Hobbs FD; Fitzmaurice DA; Mant J; Murray E; Jowett S; Bryan S; Raftery J; Davies M; Lip G
    Health Technol Assess; 2005 Oct; 9(40):iii-iv, ix-x, 1-74. PubMed ID: 16202350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of a Screening and Treatment Program for the Prevention of Fractures in Older Women: A Randomized Pragmatic Trial.
    Merlijn T; Swart KM; van Schoor NM; Heymans MW; van der Zwaard BC; van der Heijden AA; Rutters F; Lips P; van der Horst HE; Niemeijer C; Netelenbos JC; Elders PJ
    J Bone Miner Res; 2019 Nov; 34(11):1993-2000. PubMed ID: 31220365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.